Impact of hypnosis during embryo transfer on the outcome of in vitro fertilization-embryo transfer: a case-control study.
OBJECTIVE
To investigate whether hypnosis during ET contributes to successful IVF/ET outcome.


METHODS
Case-control clinical study.


METHODS
Academic Fertility and IVF Unit, Soroka Medical Center, Beer-Sheva, Israel.


METHODS
Infertile couples undergoing IVF.


METHODS
Ninety-eight IVF/ET cycles with hypnosis during the ET procedure were matched with 96 regular IVF/ET cycles.


METHODS
Comparison of clinical pregnancy and implantation rates between the two groups.


RESULTS
We obtained 52 clinical pregnancies out of 98 cycles (53.1%) with an implantation rate of 28% among hypnosis IVF/ET cycles, and 29 out of 96 (30.2%) clinical pregnancies and an implantation rate of 14.4% in the control cycles. Our overall IVF program pregnancy rate for the same period was 32.1%. Logistic regression analysis was performed emphasizing the positive contribution of hypnosis to the IVF/ET conception rates.


CONCLUSIONS
This study suggests that the use of hypnosis during ET may significantly improve the IVF/ET cycle outcome in terms of increased implantation and clinical pregnancy rates. Furthermore, it seems that the patients' attitude to the treatment was more favorable.
Fertility and IVF Unit, Soroka University Medical Center, Beer-Sheva, Israel. EliahuL@clalit.org.il
Eliahu
E
Levitas
Aldo
A
Parmet
Eitan
E
Lunenfeld
Yacov
Y
Bentov
Eliezer
E
Burstein
Michael
M
Friger
Gad
G
Potashnik
D000328:Adult; D016022:Case-Control Studies; D003131:Combined Modality Therapy / Q000706:statistics & numerical data; D004624:Embryo Transfer / Q000706:statistics & numerical data*; D005260:Female; D005307:Fertilization in Vitro / Q000706:statistics & numerical data*; D006801:Humans; D006990:Hypnosis / Q000706:statistics & numerical data*; D015994:Incidence; D007246:Infertility / Q000453:epidemiology* / Q000628:therapy*; D007557:Israel / Q000453:epidemiology; D011247:Pregnancy / Q000706:statistics & numerical data; D011256:Pregnancy Outcome / Q000453:epidemiology*; D018873:Pregnancy Rate; D011994:Recombinant Proteins / Q000008:administration & dosage; D016896:Treatment Outcome
D011994:Recombinant Proteins